12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A....
-
Upload
richard-gervais-pierce -
Category
Documents
-
view
218 -
download
1
Transcript of 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A....
![Page 1: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/1.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 1
THYROID HORMONES and ANTI-THYROID DRUGS
CECILE A. JIMENO, M.DSlides adapted from the presentation of visiting
Professor DR. RUBEN BUNAG, University of Kansas
(Katzung Chapter 38 pp. 625-639)
![Page 2: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/2.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 2
Therapeutic Overview HYPOTHYROIDISM
Administer exogenous thyroxine (T4) or triidothyronine (T3)
HYPERTHYROIDISM Surgery Radioactive iodine Drugs: thioureylenes, beta adrenergic receptor
blockers, corticosteroids, iodides
![Page 3: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/3.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 3
THYROID PHYSIOLOGY
Thyroid gland maintains metabolic homeostasis by regulating: growth and development, body temperature, and energy levels
Multiple functions are accomplished through two hormones:
[1] triiodothyronine or T3, and [2] tetraiodothyronine or T4
![Page 4: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/4.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 4
Two Thyroid Hormones
Hormones triiodothyronine tetraiodothyronine
Alias T3 T4 or thyroxine
![Page 5: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/5.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 5
Two Thyroid Hormones
Hormones triiodothyronine tetraiodothyronine
Alias T3 T4 or thyroxine
Molecular composition
one MIT plus one DIT
one DIT plus one DIT
MIT= monoiodotyrosine DIT= diiodotyrosine
![Page 6: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/6.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 6
Two Thyroid Hormones
Hormones triiodothyronine tetraiodothyronine
Alias T3 T4 or thyroxine
Molecular composition
one MIT plus one DIT
one DIT plus one DIT
Iodine content (%)
59 65
MIT= monoiodotyrosine DIT= diiodotyrosine
![Page 7: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/7.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 7
Two Thyroid Hormones
Hormones triiodothyronine tetraiodothyronine
Alias T3 T4 or thyroxine
Molecular composition
one MIT plus one DIT
one DIT plus one DIT
Iodine content (%)
59 65
Thyroglobulin ratio
1 5
MIT= monoiodotyrosine DIT= diiodotyrosine
![Page 8: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/8.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 8
THYROID HORMONE SYNTHESIS SIX MAJOR STEPS:
1. Active Transport of Iodine - across the basement membrane into the thyroid cell (iodide trapping) 2. Oxidation - of iodide & iodination of tyrosyl residues in thyroglobulin
3. Coupling - of iodotyrosine molecules within thyroglobulin to form T3 & T4
![Page 9: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/9.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 9
3. Iodination of tyrosine & coupling
Tyrosine + I -------> MIT
Tyrosine + I2 -------> 3, 5 DIT
MIT + DIT -------> 3, 5, 3’ TIT (T3) or
3, 3’, 5’ TIT (rT3)
DIT + DIT -------> 3, 5, 3’, 5’
Tetraiodothyronine (T4)
THYROID HORMONE SYNTHESIS
![Page 10: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/10.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 10
4. Proteolysis of thyroglobulin - release of free iodothyronines & iodotyrosines from colloid droplets (pinocytosis)
T3, T4Lysosomes (hydrolyzed)
(proteases, peptidases)
MIT, DIT dehalogenation recycling
5. Deiodination of iodotyrosines within the thyroid cells & recycling of iodine
6. Intrathyroidal 5’-deiodination of T4 to T3
Circ‘n
THYROID HORMONE SYNTHESIS
![Page 11: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/11.jpg)
04/21/23 11
iodide (I-) absorbed in the GIT enters an extracellular pool from which the thyroid gland removes 75 mg daily
I- is taken up by thyroid follicular cells via a membrane Na+/I- transporter
I- is coupled to tyrosine residues on the thyroglobulin molecule (organification)
formation of monoiodo- (MIT) and diiodo-tyrosine (DIT)
Thyroid Hormone Biosynthesis
![Page 12: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/12.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 12
thyroid peroxidase catalyzes coupling of two molecules of DIT to form T4, and one molecule each of MIT and DIT to form T3 --------------
thyroglobulin stored as colloid in the lumen -----
TSH signals secretion to hydrolyze thyroglobulin to free MIT, DIT, T3 & T4 -------
MIT and DIT are deiodinated for recycling while T3 & T4 are released by exocytosis
![Page 13: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/13.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 13
Peripheral Metabolism of Thyroxine
![Page 14: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/14.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 14
Pharmacokinetics of Thyroid Hormone
T3 & T4 are mostly bound to thyroxin binding globulin (TBG)
Amounts of free or unbound hormones are minimal: 0.03% T4 and 0.3% T3
Only the unbound hormones have metabolic activity
in peripheral tissues T4 is converted to T3 by iodothyronine 5’-deiodinase found mainly in liver, thyroid, and kidneys
the active hormone in most target tissues is T3
![Page 15: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/15.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 15
Thyroid hormone released mostly as T4 because T4 to T3 ratio in thyroglobulin is 5:1
peripheral metabolism of T4 is mainly by deiodination to form:
[1] T3 which is 3-4 times more potent than T4, or
[2] reverse T3 which is metabolically inactive total serum levels for T4 are higher because
more of it is released and metabolic clearance of T3 is faster
Kinetics: Peripheral Metabolism of Thyroxine
![Page 16: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/16.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 16
STEPS IN THYROID HORMONOGENESIS
Iodidetransport
I
Peroxidase(organification)
I
MIT
DIT
Thyroglobulinproduction
Coupling Dehalogenase
T3
and
T4
T3 & T4
release
RECYCLED IODINE
![Page 17: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/17.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 17
Effects of Drugs on Thyroid Hormone Production
METABOLIC STEP
A. Iodide Transport
B. Iodide OxidationC. Organification &
coupling
D. Colloid Resorption & proteolysis (Release)
INHIBITORS
A. Large amts of I-, Cl04-,
SCN-, TcO4-
B & C. Thionamide Drugs (PTU, MMI)
D. Iodine, lithium
![Page 18: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/18.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 18
Summary of Thyroid Hormone Kinetics
Thyroid Hormones T3 T4 Daily production (mg) 25 75
![Page 19: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/19.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 19
Summary of Thyroid Hormone Kinetics
Thyroid Hormones T3 T4 Daily production (mg) 25 75
Daily Metabolic clearance (L) 24 1.1
![Page 20: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/20.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 20
Summary of Thyroid Hormone Kinetics
Thyroid Hormones T3 T4 Daily production (mg) 25 75
Daily Metabolic clearance (L) 24 1.1
Total Serum levels (nmol/L) 1.5-2.9 64-132
![Page 21: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/21.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 21
Summary of Thyroid Hormone Kinetics
Thyroid Hormones T3 T4 Daily production (mg) 25 75
Daily Metabolic clearance (L) 24 1.1
Total Serum levels (nmol/L) 1.5-2.9 64-132
Biologic potency 3-4 1
![Page 22: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/22.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 22
Summary of Thyroid Hormone Kinetics
Thyroid Hormones T3 T4 Daily production (mg) 25 75
Daily Metabolic clearance (L) 24 1.1
Total Serum levels (nmol/L) 1.5-2.9 64-132
Biologic potency 3-4 1
Oral absorption (%) 95 80
![Page 23: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/23.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 23
Summary of Thyroid Hormone Kinetics
Thyroid Hormones T3 T4 Daily production (mg) 25 75
Daily Metabolic clearance (L) 24 1.1
Total Serum levels (nmol/L) 1.5-2.9 64-132
Biologic potency 3-4 1
Oral absorption (%) 95 80
Half Life (days) 1 7
![Page 24: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/24.jpg)
04/21/23 24
Reproduced with permission from McGraw-Hill Companies, Inc. “Basic & Clinical Pharmacology” 9th ed. by Katzung, Copyright © 2004, Figure 38-3, p. 629.
Hypothalamic-Pituitary Regulation[1] paraventricular nuclei in the hypothalamus secrete TRH
[2] TRH stimulates the anterior pituitary to release TSH
[3] TSH acts on the thyroid to release T3 & T4
[4] T3 & T4 act by negative feedback to inhibit formation of TRH and TSH
mechanisms for thyroid regulation
C.A. JIMENO, M.D. UPCM PHARMACOLOGY
![Page 25: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/25.jpg)
04/21/23 25
Reproduced with permission from McGraw-Hill Companies, Inc. “Basic & Clinical Pharmacology” 9th ed. by Katzung, Copyright © 2004, Figure 38-3, p. 629.
Autoregulation within the thyroid modifies thyroid hormone synthesis through blood iodine levels:
high iodine levels
inhibit iodide organification
reduced T3 & T4 synthesis hypothyroidism
mechanisms for thyroid regulation
C.A. JIMENO, M.D. UPCM PHARMACOLOGY
![Page 26: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/26.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY26
PB = plasma binding protein F = transcription factor R = receptor PP=proximal promoter proteins
T3 receptors belong to a superfamily of nuclear receptors (c-erb includes receptors for steroid hormones and vitamins A and D) many T3 receptors are found in responsive tissues like pituitary, liver, kidney, heart, skeletal muscle, lung, and intestine
Thyroid Hormone Mechanism of Action
![Page 27: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/27.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 27
Thyroid Hormone Mechanism of Action
PB = plasma binding protein F = transcription factor R = receptor PP=proximal promoter proteins
T3 & T4 are dissociated from thyroid-binding proteins nter target cells by diffusion or transport in the cytoplasm 5’-deiodinase converts T4 to T3 T3 enters the nucleus to bind to T3 receptors more RNA formed increase protein synthesis
![Page 28: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/28.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY28
T3 Mechanism of Action
T3 acts on Intracellular thyroid hormone receptors (TRs) located in all cells of the body
TR monomers interact with retinoic acid X receptor (RXR) to form heterodimers
in the absence of T3 the TR:RXR heterodimer associates with a co-repressor complex that binds to DNA to inhibit gene expression
![Page 29: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/29.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 29
T3 Mechanism of Action
in the presence of T3, the co-repressor complex dissociates, coactivators form to stimulate gene expression
binding to TR dimers thus serves as a molecular switch from inhibition to activation of gene expression
![Page 30: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/30.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 30
Thyroid hormone effects
Generally responsible for optimal growth, development, function, and energy levels in all tissues Excess hyperthyroidism
(thyrotoxicosis) Inadequacy hypothyroidism
(myxedema)
![Page 31: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/31.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 31
Thyroid Hormone Effects
1. Nervous, musculoskeletal, and reproductive tissues: nervousness, emotional lability, muscle weakness and fatigue, osteoporosis, menstrual irregularities
2. Calorigenic effect: increased oxygen consumption, sweating
![Page 32: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/32.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 32
3. Sympathetic hyperactivity due to increased -adrenergic sensitivity dramatic cardiovascular effects including: tachycardia, increased stroke volume and cardiac output, high-output heart failure, arrhythmia, angina
4. Metabolic effects: decreased cholesterol and triglycerides; increased basal metabolic rate, hyperglycemia, and appetite
Thyroid Hormone Effects
![Page 33: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/33.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 33
Thyroid Preparations Major clinical use of T3 & T4 is for hormone
replacement therapy in hypothyroidism Involves replacement of thyroid hormone adequate
to meet the patient’s needs Dose for replacement: 1.6-1.7 mcg/kg SLOW replacement for the elderly, CAD, arrhythmia Indications?
Post-procedural hypothyroidism Endemic goiter Congenital hypothyroidism: cretinism Any cause of hypothyroidism i.e. thyroiditis Suppression of growth of nodules, thyroid CA (dose is
higher: 2.2-3.0 mcg/kg)
![Page 34: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/34.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 34
Thyroid Preparations
1. Synthetic levothyroxine [T4]: the preparation of choice for replacement & suppression therapy because of its stability, uniform content, low cost, long half-life (7 days), and conversion to produce both T3 & T4
2. Desiccated thyroid, though inexpensive, is not recommended for replacement therapy because of its antigenicity, instability, and variable hormone content
![Page 35: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/35.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 35
3. Liothyronine, [T3] 3-4 times more active than levothyroxine Not recommended for routine replacement
therapy because of its higher cost, shorter half-life (24 hours), and greater potential for cardiotoxicity
4. Liotrix, a 4:1 combination of synthetic T4 and T3, also expensive with the same disadvantages as liothyronine
Thyroid Preparations
![Page 36: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/36.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 36
Thyrotoxicosis (vs hyperthyroidism)
Is the consequence of excessive thyroid hormone action due to
Causes:
1. Diffuse toxic goiter (Graves’ disease)
2. Toxic adenoma
3. Toxic multinodular goiter (Plummer’s)
4. Painful subacute thyroiditis
5. Silent thyroiditis e.g. lymphocytic &
postpartum variations
6. Iodine-induced hyperthyroidism
7. Excessive pituitary TSH or trophoblastic
disease
8. Excessive ingestion of thyroid hormones
![Page 37: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/37.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 37
Clinical Features
Signs & symptoms are due to the effects of excess thyroid hormone in the circulation
Severity of signs & symptoms may be related to the duration of the illness, magnitude of hormone excess & the age of the patient
![Page 38: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/38.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 38
Signs & Sx of Hyperthyroidism
SYMPTOMS Weakness & Fatigue Heat intolerance Nervousness Increased sweating Tremor Palpitations Increased appetite Weight loss Hyperdefecation Dyspnea Menstrual a(N)
SIGNS Goiter/thyroid bruit Hyperkinesis Ophthalmopathy Lid retractions/stare Lid lag Tremor Warm, moist skin Muscle weakness Hyperreflexia Tachycardia/arrhythmia Widened pulse pressure
![Page 39: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/39.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 39
Hyperthyroidism
![Page 40: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/40.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 40
![Page 41: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/41.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 41
Antithyroid Drugs
[1] Thioamides: methimazole propylthiouracil
[2] Iodides: potassium iodide solution [3] Radioactive Iodine (RAI)[4] Other Drugs:
anion inhibitors -adrenergic blockers
![Page 42: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/42.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 42
Anti-thyroid Drugs THIOUREYLENE or THIONAMIDES
Propylthiouracil, Methimazole/Thiamazole, Carbimazole (pro-drug of methimazole)
MOA: inhibit the thyroid peroxidase-mediated iodination & coupling steps
These drugs are preferentially iodinated, depriving thyroglobulin of iodide and shutting down the synthesis of thyroid hormones
Accumulate readily in the thyroid gland for treatment of thyrotoxicosis
![Page 43: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/43.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 43
Thioanamide/Thioureylene Drugs
Methimazole is 10x more active than PTU Plasma half-lives: 6 hr for MMI & 1.5 hr for PTU Additional MOA: PTU but not methimazole, affects
the processing of T4 to T3 in the peripheral tissues (inhibition of deiodinase enzyme)
Since T3 is 10x as active as T4 this conversion step is important
![Page 44: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/44.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY
44
Thioamides: methimazole & propylthiouracil slow onset of action requiring 3-4 weeks to deplete T4 stores multiple mechanisms of action including:
major action to prevent hormone synthesis by inhibiting peroxidase reactions to block iodine organification
block iodotyrosine coupling inhibit peripheral deiodination of T3 & T4
adverse reactions occur in 3-12% of treated patients: most common: maculopapular pruritic rash rarely: urticarial rash, vasculitis, arthralgia, lupus-
like reaction, jaundice, hepatitis hypothrombinemia most dangerous – agranulocytosis
![Page 45: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/45.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 45
Side Effects of Thioureylenes
Rash, urticaria – in as much as 20% of users; usually transient even w/o treatment
Auto-immune (lupus-like) nephritis, PAN Granulocytopenia,a granulocytosis: RARE
but potentially fatal Watch out for sore throat, fever, diarrhea
![Page 46: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/46.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 46
Other anti-thyroid Drugs (Adjunct)
Monocovalent anions: block thyroid hormone synthesis by competitively inhibiting the active transport of iodide into the thyroid gland Pertechnetate, Perchlorate: little clinical use High dose iodides: potassium iodide, SSKI,
Lugol’s solution, intravenous contrast agents Watch out for angioedema with iodides
![Page 47: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/47.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 47
Anion Inhibitors & -adrenergic
Blockers Monovalent ions as perchlorate (ClO4-),
pertechnetate (TcO4-), and thiocyanate (SCN-) block iodide uptake through competitive inhibition of the iodide transport mechanism, but their effectiveness is unpredictable
Potassium perchlorate is no longer used clinically because it causes aplastic anemia
![Page 48: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/48.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 48
Iodinated contrast media (ipodate and iopanoic acid by mouth, or diatrizoate IV) though not FDA approved, act by inhibiting conversion of T4 to T3 in liver, kidney, pituitary, and brain
Since many symptoms of thyrotoxicosis result from sympathetic hyperactivity, guanethidine or -adrenergic blockers have also been used for treatment
Anion Inhibitors & B-adrenergic Blockers
![Page 49: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/49.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 49
Iodides: potassium iodide solution
Many thyroid actions including: inhibition of hormone release by reducing
thyroglobulin proteolysis decrease in size and vascularity of the
hyperplastic gland Thyrotoxic symptoms improve within 2-7 days,
but should not be used alone because the gland “escapes’ from iodide block after 2-8 weeks and withdrawal may result in severe thyrotoxicosis
Avoid chronic use in pregnancy as iodides cross the placenta and can cause fetal goiter
![Page 50: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/50.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 50
Iodides: potassium iodide solution
Advantages: simplicity, inexpensive, relatively nontoxic, and absence of glandular destruction
ADVERSE reactions (uncommon): acneiform rash, swollen salivary glands, mucous membrane ulceration, conjunctivitis, rhinorrhea, metallic taste, drug fever, bleeding disorders, anaphylaxis
DISADVANTAGES: “escape”, aggravation of thyrotoxicosis, allergic reactions, & increased intraglandular iodine which can delay onset of thioamide therapy or prevent use of radioactive iodine therapy for several weeks
![Page 51: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/51.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 51
Beta-adrenergic receptor blocking drugs Act peripherally rather than at the thyroid gland MOA: uncertain but may relate to inhibition of
deiodination= peripheral conversion of T4 to T3 Also blocks the sympathetic (adrenergic) effects of
hyperthyroidism esp. on the heart Avoid in patient with ASTHMA
Other anti-thyroid Drugs (Adjunct)
![Page 52: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/52.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 52
Corticosteroids Inhibit peripheral conversion of T4 to T3 Immunosuppression of thyroid-stimulating
antibodies Antipyretic May be used for treatment of adrenal insufficiency
in pts with thyroid storm
Other anti-thyroid Drugs (Adjunct)
![Page 53: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/53.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 53
IODIDETRANSPORT
HORMONESYNTHESIS
HORMONESECRETION
I- TPOI-H2O2
Io
T4
T3
DITMIT
Tg
T4, T3
DIT, MIT
Tyr I-
Tg
T4 T3
Tyr I-
![Page 54: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/54.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 54
STEPS IN THYROID HORMONOGENESIS
Iodidetransport
I
Peroxidase(organification)
PTU, MMZ
I
MIT
DIT
Thyroglobulinproduction
Coupling
PTU, MMZ
Release
T3
and
T4
T3 & T4
release
RECYCLED IODINE
Iodides Iodides, Li
![Page 55: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/55.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 55
Radioactive Iodine Therapy
Used for definitive therapy or ablation The only isotopes used for treatment of thyrotoxicosis Uses the ff radioisotopes: I123 or I131
Side- effects are minimal: avoid in children (may inhibit bone growth) and pregnant women or those intending pregnancy
Contraceptives are encouraged among those who are sexually active:
![Page 56: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/56.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 56
Radioactive Iodine (RAI) Given as oral solution or capsulized, 131I is
rapidly absorbed and concentrated in the thyroid gland
Thyroid parenchymal destruction becomes evident within weeks in the form of epithelial swelling, necrosis, follicular disruption, edema, and leukocyte infiltration
Therapeutic effect depends on emission of beta rays with:
(a) penetration range of 400-2000 mm and
(b) effective half-life of 5 days
![Page 57: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/57.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 57
Advantages: easy administration, effectiveness, low expense, & absence of pain
Major disadvantage is induction of hypothyroidism
Main contraindication is pregnancy as RAI crosses the placenta and is excreted in breast milk
Radioactive Iodine (RAI)
![Page 58: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/58.jpg)
04/21/23 58
Drugs Affecting T3-T4 Synthesis
Anions (perchlorate, pertechnetate, & thiocyanate)
compete with I- uptake
RAI causes selective thyroid destruction
Iodide (high levels) reduce T3-T4 release by inhibiting thyroglobulin proteolysis
Thioamides inhibit peroxidase to block organificationC.A. JIMENO, M.D. UPCM PHARMACOLOGY
![Page 59: 12/8/2015C.A. JIMENO, M.D. UPCM PHARMACOLOGY1 THYROID HORMONES and ANTI-THYROID DRUGS CECILE A. JIMENO, M.D Slides adapted from the presentation of visiting.](https://reader035.fdocuments.us/reader035/viewer/2022062804/5697bf821a28abf838c85f4f/html5/thumbnails/59.jpg)
04/21/23 C.A. JIMENO, M.D. UPCM PHARMACOLOGY 59
THANK VERY
MUCH!